Intranasal Dexmedetomidine Sedation as Adjuvant Therapy in Acute Asthma Exacerbation With Marked Anxiety and Agitation

Research output: Contribution to journalArticlepeer-review

Abstract

We describe 2 patients with acute asthma exacerbation who were admitted to the emergency department (ED) with severe agitation and restlessness as a prominent finding, for which bedside asthma treatment sedation with intranasal dexmedetomidine was performed. In both cases, dexmedetomidine allowed the patients to rest and improved tolerance to treatment. Dexmedetomidine is a unique sedative with an excellent safety profile and minimal effect on respiratory function. These properties render it particularly promising for the management of severe agitation in children admitted to the ED with acute asthma exacerbation.

Original languageEnglish
JournalAnnals of Emergency Medicine
DOIs
Publication statusAccepted/In press - 2016

ASJC Scopus subject areas

  • Emergency Medicine

Fingerprint

Dive into the research topics of 'Intranasal Dexmedetomidine Sedation as Adjuvant Therapy in Acute Asthma Exacerbation With Marked Anxiety and Agitation'. Together they form a unique fingerprint.

Cite this